Innovative Drug Delivery LIDDS specializes in proprietary NanoZolid® technology, enabling controlled local drug release for up to six months, which may appeal to pharmaceutical companies seeking advanced drug formulation solutions.
Strategic Acquisitions The recent acquisition of Noviga Research AB, a cancer drug development company, indicates LIDDS' expansion into oncology, presenting opportunities to collaborate or integrate complementary cancer treatment technologies.
Leadership Transition With new CEO Jenni Björnulfson appointed in late 2023, there may be opportunities to engage with the company's evolving strategic focus and explore partnership avenues aligned with leadership priorities.
Collaborative Development LIDDS has ongoing agreements withJohnson & Johnson for oncology product development, highlighting potential avenues for co-development, licensing, or service partnerships in advanced drug delivery.
Growth & Funding Despite modest revenue levels, LIDDS has secured substantial funding of $4.4M, indicating ongoing R&D investments and potential for future contract opportunities in biotechnological innovation and clinical development services.
LIDDS uses 8 technology products and services including MySQL, Google Charts, jQuery Migrate, and more. Explore LIDDS's tech stack below.
| LIDDS Email Formats | Percentage |
| First.Last@liddspharma.com | 47% |
| First.MiddleLast@liddspharma.com | 3% |
| First.Last@liddspharma.com | 47% |
| First.MiddleLast@liddspharma.com | 3% |
Biotechnology ResearchUppsala, Sweden2-10 Employees
LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®. With NanoZolid®, LIDDS can formulate drugs for local administration, with a maintained and controlled release for up to six months.
Company Overview
Media & News
Funding & FinancialsLIDDS has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Feb 22, 2022 in the amount of $4.4M.
LIDDS's revenue is estimated to be in the range of $1M
Funding & FinancialsLIDDS has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Feb 22, 2022 in the amount of $4.4M.
LIDDS's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com